Last reviewed · How we verify

NCT04163666

Effects of Mirror Therapy and Cognitive Therapeutic Exercise in Stroke Patients

Status unknown NA Last updated 27 June 2022
What this trial tests

NA trial testing Mirror therapy in Stroke in 152 participants. Status unknown.

Timeline
1 January 2020
Primary endpoint
30 October 2022
31 October 2023

Quick facts

Lead sponsorUniversidad de Burgos
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment152
Start date1 January 2020
Primary completion30 October 2022
Estimated completion31 October 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Burgos

Who can join

Eligibility, any sex, with Stroke or Hemiparesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized clinical trial aimed at patients with a diagnosis of residual hemiparesis due to ischemic or hemorrhagic stroke. Its objective is to evaluate the effects of the mirror therapy and cognitive therapeutic exercise, both in combination with task-oriented motor learning, to achieve maximum functionality of the affected upper member,

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of home-based mirror therapy and cognitive therapeutic exercise on the improvement of the upper extremity functions in patients with severe hemiparesis after a stroke: a protocol for a pilot randomised clinical trial.
    Gonzalez-Santos J, Soto-Camara R, Rodriguez-Fernández P, Jimenez-Barrios M, et al · · 2020 · cited 6× · PMID 32978182 · DOI 10.1136/bmjopen-2019-035768

Verify or expand the search:

Other trials of Mirror therapy

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Universidad de Burgos trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04163666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing